» Articles » PMID: 27114331

Novel Correlates Between Antimüllerian Hormone and Menstrual cycle Characteristics In African-American Women (23-35 years-old)

Overview
Journal Fertil Steril
Date 2016 Apr 27
PMID 27114331
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To characterize normative antimüllerian hormone (AMH) levels and ascertain which factors are associated with AMH in a large cohort of reproductive-age women.

Design: Cross-sectional study.

Setting: Not applicable.

Patient(s): A total of 1,654 African-American women (AAW) ages 23-34 at recruitment.

Intervention(s): Not applicable.

Main Outcome Measure(s): Serum AMH measured using an ultrasensitive ELISA.

Result(s): The median AMH was 3.18 ng/mL, and there was a significant, but nonlinear, relationship between age and AMH, with levels peaking at age 25. As AMH was not normally distributed, log transformation was performed and used for all analyses. In a multivariable age-adjusted model, body mass index, current use of hormonal contraception, and history of a thyroid condition were inversely associated with AMH, while history of abnormal menstrual bleeding and menstrual cycles longer than 35 days were positively associated with AMH.

Conclusion(s): While age is correlated with AMH, it accounts for only a portion of the variation seen. This study adds valuable information to the existing literature on normative AMH levels in young reproductive-age women. While our findings fill a critical data gap for ovarian reserve in AAW, the insights gained will be of benefit for all women.

Citing Articles

Follicle-Stimulating Hormone Receptor and Estrogen Receptor Gene Polymorphisms in Women With Discordant Follicle-Stimulating Hormone and Anti-Mullerian Hormone Levels.

Aktas G, Bertizlioglu M, Yilmaz S, Kebapcilar A, Celik C, Secilmis O Cureus. 2024; 16(5):e60446.

PMID: 38883018 PMC: 11179686. DOI: 10.7759/cureus.60446.


Association between serum 25-hydroxyvitamin D and antimüllerian hormone levels in a cohort of African-American women.

Subramanian A, Harmon Q, Bernardi L, Carnethon M, Marsh E, Baird D Fertil Steril. 2023; 121(4):642-650.

PMID: 38145700 PMC: 10978232. DOI: 10.1016/j.fertnstert.2023.12.023.


Associations of reproductive and breastfeeding history with anti-Müllerian hormone concentration among African-American women of reproductive age.

Komorowski A, Jiang C, Berrocal V, Neff L, Wise L, Harmon Q Reprod Biomed Online. 2023; 47(5):103323.

PMID: 37751677 PMC: 10828113. DOI: 10.1016/j.rbmo.2023.103323.


Geographical Diversity in the Age Specific Anti Müllerian Hormone Levels in Infertile Women: A Hospital based Cohort Study.

Jaffar M, Ahmad S, Monica , Ashraf M, Shaik S, Asif M J Hum Reprod Sci. 2023; 16(1):29-35.

PMID: 37305773 PMC: 10256946. DOI: 10.4103/jhrs.jhrs_163_22.


Association between uterine fibroids and antimüllerian hormone concentrations among African American women.

Bernardi L, Waldo A, Berrocal V, Wise L, Marsh E Fertil Steril. 2022; 117(4):832-840.

PMID: 35105447 PMC: 8983564. DOI: 10.1016/j.fertnstert.2021.12.019.


References
1.
Pigny P, Merlen E, Robert Y, Cortet-Rudelli C, Decanter C, Jonard S . Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab. 2003; 88(12):5957-62. DOI: 10.1210/jc.2003-030727. View

2.
Dolleman M, Faddy M, van Disseldorp J, van der Schouw Y, Messow C, Leader B . The relationship between anti-Müllerian hormone in women receiving fertility assessments and age at menopause in subfertile women: evidence from large population studies. J Clin Endocrinol Metab. 2013; 98(5):1946-53. DOI: 10.1210/jc.2013-3105. View

3.
Baird D, Harmon Q, Upson K, Moore K, Barker-Cummings C, Baker S . A Prospective, Ultrasound-Based Study to Evaluate Risk Factors for Uterine Fibroid Incidence and Growth: Methods and Results of Recruitment. J Womens Health (Larchmt). 2015; 24(11):907-15. PMC: 4649767. DOI: 10.1089/jwh.2015.5277. View

4.
Cook C, Siow Y, Brenner A, Fallat M . Relationship between serum müllerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women. Fertil Steril. 2002; 77(1):141-6. DOI: 10.1016/s0015-0282(01)02944-2. View

5.
Broer S, Eijkemans M, Scheffer G, van Rooij I, de Vet A, Themmen A . Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women. J Clin Endocrinol Metab. 2011; 96(8):2532-9. DOI: 10.1210/jc.2010-2776. View